◼ Archived
Health
🔮 fades ✓
Daraxonrasib for Previously Treated RAS -Mutant Non–Small-Cell Lung Cancer
The FDA has approved daraxonrasib for the treatment of previously treated RAS-mutant non-small-cell lung cancer and pancreatic cancer.